Sarcopenia, defined as an irrevocable loss of skeletal muscle mass and strength in aged individuals 1,2 , results in frailty and a high risk of mortality 3, 4 , thus greatly increasing government healthcare expenditures given the expanding elderly population 5 . The mechanisms involved in the development of sarcopenia are poorly understood but include changes in skeletal muscle metabolism and compromised regeneration and muscle stem cell function [6] [7] [8] [9] . Widely regarded as critical to the regeneration process, satellite cells (SCs) reside next to the myofiber plasma membrane of young skeletal muscle myofibers 10 . Indeed, ablation experiments demonstrate that SCs are bona fide muscle stem cells, as they exhibit regenerative and self-renewing properties [11] [12] [13] .
Sarcopenia, defined as an irrevocable loss of skeletal muscle mass and strength in aged individuals 1, 2 , results in frailty and a high risk of mortality 3, 4 , thus greatly increasing government healthcare expenditures given the expanding elderly population 5 . The mechanisms involved in the development of sarcopenia are poorly understood but include changes in skeletal muscle metabolism and compromised regeneration and muscle stem cell function [6] [7] [8] [9] . Widely regarded as critical to the regeneration process, satellite cells (SCs) reside next to the myofiber plasma membrane of young skeletal muscle myofibers 10 . Indeed, ablation experiments demonstrate that SCs are bona fide muscle stem cells, as they exhibit regenerative and self-renewing properties [11] [12] [13] .
The poor regenerative capacities of sarcopenic muscle are reportedly due to environmental impairment of aged SC function 6, 7, 9, [14] [15] [16] . Systemic cues within the aged environment compromise SC activity, and exposure to a young environment improves regeneration of aged muscle and SC differentiation [17] [18] [19] [20] [21] [22] . Notably, the effects of the aged environment can be overcome, as transplantation of young myofibers with their attached SCs prevents age-associated loss of muscle mass and strength 23 .
Fibroblast growth factor receptor (FGFR) tyrosine kinases have important roles in coordinating extracellular signals with internal SC regulatory networks. Although FGFRs indirectly promote proliferation by repressing myoblast differentiation, they do not directly function as mitogens [24] [25] [26] . SCs express FGFR1, which prevents terminal differentiation 24, [26] [27] [28] , and FGFR4 (ref. 28) , which plays a part in cell fate determination during embryonic muscle development 29 . Intracellular signals activated by FGFR1 include both extracellular signal-regulated kinase and p38α and p38β (here called p38α/β) mitogen-activated protein kinase (MAPK) pathways, which regulate SC proliferation and asymmetric division, respectively 30, 31 .
Members of the MAPK family have diverse and complicated roles in the maintenance, proliferation, asymmetric division and differentiation of SCs. Extracellular signal-regulated kinase is necessary but not sufficient for myoblast proliferation 30, 32 and does not regulate differentiation 28, 30 , but it is implicated in age-related loss of SC proliferative capacity 32 . Signaling by p38α/β MAPK is involved in the exit of SCs from quiescence 31, 33 , asymmetric division of SCs 33 and differentiation of SCs in vivo 33 . The p38α/β MAPKs and p38γ MAPK also play parts in myogenic differentiation 34, 35 . Because of the diverse roles that MAPKs have in regulating SC function, their relative activities are probably spatially and temporally context dependent.
Here, we show that SCs from aged mice possess a cell-autonomous defect in self-renewal that cannot be rescued by exposure to a young environment. We demonstrate that these cell-intrinsic deficits arise from an impaired response to FGF ligands and elevated p38α/β MAPK activity and, when corrected, rescue the self-renewal capacity of SCs from aged mice. Thus, our data identify cell-autonomous FGF-p38α/β MAPK signaling as a critical pathway deregulated in SCs from aged mice and highlight a unique therapeutic opportunity for clinical management of age-associated sarcopenia.
RESULTS
SCs from aged mice are not rescued by a young environment Myofiber-associated SCs from aged mice fail to expand as efficiently as those from young mice (Fig. 1a, Supplementary Fig. 1a -e and Supplementary Methods), and more SCs from aged mice are MyoD + and MyoD + myogenin + than SCs from young mice, indicating that SCs from aged mice are more committed to differentiation when placed in culture (Fig. 1a) 18, 36 . As parabiosis and transplantation experiments show that a young environment restores the function of SCs from aged mice 18, 21, 22 , we developed a heterochronic culture a r t i c l e s 2 6 6 VOLUME 20 | NUMBER 3 | MARCH 2014 nature medicine assay (Fig. 1b) to specifically assess whether a young local environment (intact myofibers) could restore the ability of SCs from aged mice to expand in culture. SCs isolated from young or aged mice constitutively expressing GFP under control of the β-actin promoter (βActGFP mice) were seeded onto unlabeled myofibers from a young mouse and fixed for analysis at 24 h (Fig. 1c ) and 72 h (Fig. 1d) after seeding. Quantification of endogenous host SCs marked by syndecan-4 (ref. 37) (Fig. 1c) and donor GFP + SCs (Fig. 1c,d ) revealed equivalent attachment of SCs from young and aged donors at 24 h (Fig. 1e ). There were threefold more young donor cells present at 72 h in culture than there were aged donor cells (Fig. 1f) . Seeding of SCs from aged mice onto myofibers from young mice failed to rescue expansion of these SCs, and we hypothesized that a young global environment, including circulating factors, may be necessary to rescue the self-renewal and subsequent expansion of SCs from aged mice. Therefore, we transplanted myofiber-associated βActGFP-marked SCs from young and age mice into young wild-type hosts concurrent with barium chloride injury 23 ( Fig. 1g and Supplementary  Fig. 1f,g ). Although both sets of SCs fused into host myofibers (Fig. 1h) , we detected a 50% reduction in the number of aged donorderived cells in the SC position 30 d after transplantation compared to the number of young donor-derived SCs (Fig. 1i) . By 60 d after transplantation, we detected few aged donor-derived SCs, whereas young donor-derived cell numbers remained constant (Fig. 1i,j) .
SCs from aged mice fail to self-renew and elevate p38 MAPK activity As transplanted SCs from aged mice were not maintained in a young host environment, we tested whether SCs from aged mice were capable of generating quiescent daughter cells in culture ( Fig. 2a-d) 33 . Myofibers treated with the mitotoxin 1-β-d-arabinofuranosylcytosine (AraC) for 3-5 d after isolation yielded similar numbers of surviving SC daughters in cultures of SCs from young and aged mice but a lower number of quiescent Pax7 + daughters and a greater number of postmitotic differentiated cells in cultures of SCs from aged mice compared to those from young mice (Fig. 2b,d) . We then washed out AraC and maintained cultures for an additional 3 d to assess myoblast expansion and SC self-renewal as previously described 33 . In contrast to cultures of SCs from young mice, myofiber-associated SCs from aged mice were incapable of further expansion and self-renewal upon AraC removal (Fig. 2c,d) . 28. Figure 1 
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One explanation for the poor engraftment of SCs from aged mice is that the cells fail to properly activate. Given the prominent role of p38α/β MAPK signaling in regulating SC activation 31 and asymmetric division 33 , we systematically interrogated the integrity of this signal transduction cascade in SCs from aged mice. Myofiber-associated SCs from young mice activate within 30 min of injury or explantation, as measured by p38α/β MAPK phosphorylation 31 . Notably, we found enhanced p38α/β MAPK phosphorylation (phospho-p38) in myofiber-associated SCs from aged mice compared to those from young mice analyzed 1 h after isolation (Fig. 2e,f) , as well as increased phosphorylated MAPKAPK-2 (phospho-MK-2), a direct target of p38α/β MAPK (Fig. 2e,f) . Consistent with these culture data, we observed a fourfold increase of phospho-MK-2 in sublaminar SCs in aged compared to young skeletal muscle sections (Fig. 2g,h ).
To investigate the molecular mechanisms underlying the behavior of SCs from aged mice, we collected RNA from FACS-isolated SCs pooled from multiple animals for an unbiased gene expression analysis to identify gene ontology terms and molecular pathways that change significantly between SCs from young and aged mice. We identified a general reduction in the expression of genes associated with asymmetric division 33 ( Fig. 3a and Supplementary Fig. 2) , cell growth and differentiation in SCs from aged mice compared to expression of those genes in SCs from young mice ( Supplementary Fig. 3 33 , we expected a reduced percentage of cells with asymmetric phospho-p38 from aged mice as compared to the percentage of SCs with asymmetric phospho-p38 from young mice, despite elevated p38 signaling in SCs from aged mice. Quantitative analysis of myofiber-associated SCs ( Fig. 3b and Supplementary Video 1) revealed a 50% reduction in the numbers of asymmetric phospho-p38 SCs from aged mice compared to the numbers of SCs from young mice with asymmetric phospho-p38 (Fig. 3c) . Inhibition of p38α/β MAPK signaling with 25 µM SB, an imidazole-based ATP competitive inhibitor of the α and β isoforms of p38 MAPK, virtually eliminated asymmetric phospho-p38 + SCs after isolation from young and aged mice ( Fig. 3c and Supplementary Fig. 4) . Notably, partial inhibition of p38α/β MAPK signaling increased the percentage of SCs with asymmetric phospho-p38 from aged mice but did not affect the percentage of asymmetric phospho-p38 + SCs from young mice (Fig. 3c) .
The restoration of asymmetric phospho-p38 by partial inhibition of p38α/β MAPK suggests that self-renewal in SCs from aged mice may be similarly rescued. We assayed SC self-renewal after isolation from aged mice using a previously published dye retention assay 33 , whereby cell-permeable carboxyfluorescein diacetate-succinimidyl ester (CFDA-SE) is acquired by all cells but is retained only in quiescent or differentiated noncycling cells (Fig. 3d,e) . Quiescent Pax7 + SCs that retained CFDA-SE were present in cultures of SCs from young mice but were nearly absent in SCs from aged mice (Fig. 3f) . Partial inhibition of p38α/β MAPK with either SB or BIRB 796, an alternate p38αβ inhibitor ( Fig. 3f and Supplementary Fig. 4) , restored the number of label-retaining Pax7 + SCs from old mice nearly to the numbers seen in SCs from young mice (Fig. 3f) .
FGF and p38a/b MAPK pathways are involved in SC self-renewal The high amount of FGF-2 observed in skeletal muscles from aged mice 32 and the FGF-dependent activation of p38α/β MAPK signaling prompted us to compare FGFR1 activation and signaling in SCs from aged versus young mice (Supplementary Fig. 5 ). Phospho-FGFR + SC numbers were lower in cultures of SCs from aged mice at 24 h after isolation compared to those from young mice (Fig. 4a,b) , and inhibition of FGFR1 signaling reduced p38α/β MAPK signaling in SCs from young mice but not in SCs from aged mice (Fig. 4c) . We then examined FGF signaling by single-cell analyses using Sdc4 as an SC marker (Fig. 4d) to detect p38α/β MAPK protein (Fig. 4e) in SCs isolated from equivalent young and aged muscle masses. Addition of FGF-2 stimulated p38α/β MAPK phosphorylation in SCs from young mice but not in those from aged mice (Fig. 4f) . Inhibition of FGFR1 signaling with the FGFR inhibitor SU5402 eliminated FGF-stimulated phosphorylation of p38α/β MAPK in SCs from young mice but had no effect on p38αβ phosphorylation in SCs from aged mice (Fig. 4g) , highlighting the insensitivity of p38α/β MAPK in aged SCs to FGF addition. We next tested whether inhibiting FGFR1 signaling with SU5402 affected self-renewal via the CFDA-SE label retention assay (Fig. 4h) . The number of label-retaining Pax7 + cells from young mice, but not from aged mice, was significantly decreased by inhibition of FGFR signaling (Fig. 4i) .
The insensitivity of SCs from aged mice to FGF-2 and their elevated p38α/β MAPK activity, coupled with the reported upregulation of FGF-2 in muscles from aged mice 32 , suggest that aged muscle is compensating for attenuated FGFR1 signaling in aged SCs. Therefore, we used an inducible constitutively active FGFR1 (iFR1) 38, 39 to provide ligand-independent FGFR1 signaling via small molecule-induced dimerization 38 . Upon isolation, myofiber-associated SCs were transfected with iFR1 expression vectors, treated with B/B Homodimerizer to activate iFR1 (refs. 38,39 ) and harvested at 72 h immunofluorescence analysis (Fig. 5a) ; then iFR1 + SCs were scored for Pax7 and myogenin (Fig. 5b) . In the absence of iFR1 dimerization, myogenin + cells predominated in SC cultures derived from aged mice, whereas Pax7 + cells were more prevalent in cultures from young mice (Fig. 5c) . Activation of iFR1 increased the proportion of Pax7 + cells at the expense of myogenin + cells in cultures of SCs from both young and old mice, whereas nearly all SCs were Pax7 + following iFR1 activation (Fig. 5c) . Accompanying the increase in Pax7 + cells was a subcellular relocalization of phospho-FGFR and iFR1 (Fig. 5d,e) . The diffuse distribution of iFR1 became localized and asymmetric upon receptor activation (Fig. 5f) . Moreover, upon iFR1 activation, p38 p38 p38 p38 p38 p38 p38 P P P P P P P P P P P P P P P p38 p38 p38 p38 p38 P P P P P P P P P P p38 p38 p38 p38 p38 P P P P P P P P P P P P P P P P P P P P P P P P P P P P Lineage committed the majority of phospho-p38α/β MAPK (Fig. 5e,f) colocalized asymmetrically with iFR1 in SCs from young mice as well as those from aged mice (Fig. 5f) . A CFDA-SE dye retention assay (Fig. 5g) identified self-renewed quiescent SCs from young and old mice following iFR1 activation (Fig. 5h) . Addition of B/B Homodimerizer or FGF-2 yielded similar numbers of CFDA-SE + label-retaining cells in cultures of SCs from young mice (Fig. 5i) , indicating equivalent SC self-renewal from ectopic iFR1 signaling or FGF-2 addition in SCs from young mice (Fig. 5j) . In contrast, iFR1 activation but not FGF-2 addition increased self-renewal of SCs from aged mice identified as Pax7 + CFDA-SE label-retaining SCs (Fig. 5i,j) . Ectopic activation of FGFR1 signaling via iFR1 and partial inhibition of p38α/β MAPK in SCs of aged mice restores asymmetric localization of phospho-p38α/β MAPK, partially rescuing self-renewal in culture, suggesting that both treatments should enhance the engraftment of SCs from aged mice. As it is not feasible to test iFR1 activation in transplantation assays because the iFR1 transfections are transient and the levels of B/B Homodimerizer and dosing in vivo have not been determined, we transplanted SCs from aged and young mice that had been pretreated with 10 µM SB. Freshly isolated myofibers with associated SCs from young and aged βActGFP mice were incubated in DMSO carrier or 10 µM SB for 12 h and then transplanted into young host muscles with barium chloride to elicit muscle injury (Fig. 6a) . Thirty days after injection, muscles were harvested and donor SCs identified by c-Met immunostaining and GFP fluorescence (Fig. 6b) . The presence or absence of SB had no significant effect on young donor SC engraftment, but pretreatment of aged donor SCs with 10 µM SB restored the engraftment of SCs from aged mice to a level similar to that observed for young donor SCs 30 d after injection (Fig. 6c) .
DISCUSSION
Skeletal muscle function and mass decline with age, beginning around age 40 in men 40 . Sarcopenia, a more severe loss of muscle mass and function, leads to frailty, increased morbidity and increased healthcare costs 2,4,5 . The mechanisms involved in sarcopenia are only beginning to be understood but clearly involve major metabolic changes in muscle tissue 41 and reductions in skeletal muscle regeneration 6, 7, 9 . Previous work has demonstrated that an altered global environment in aged mice inhibits SC function, suggesting that SCs from aged mice might be completely rescued simply by exposure to a young environment [18] [19] [20] [21] [22] . The present study aimed to address two major unresolved issues: (i) whether SCs from aged mice exhibit cell-intrinsic alterations in self-renewal and (ii) what the long-term behavior of SCs from aged mice transplanted to a young environment is. We found that SCs from aged mice fail to self-renew even when transplanted into a young host environment. The failure of the young environment to rescue self-renewal of SCs from aged mice led to the identification of cell-autonomous deficits in these cells; alterations in an FGF-p38α/β MAPK signaling pathway appear at the core of these age-associated deficits.
Freshly isolated SCs from aged mice show increased p38α/β MAPK activity when compared to SCs isolated from young mice. Accompanying the elevated p38α/β MAPK signaling in aged SCs is an attenuation of FGFR1 stimulation by FGF ligands. Thus, it is likely that the aged environment is responsible for the elevated p38α/β signaling, possibly from increased cellular stress and inflammatory responses, but is not arising from the higher levels of FGF-2 present in aged muscle, as p38α/β signaling in SCs from aged mice is insensitive to FGF-2. We propose that the aged environment contributes to the elevated p38α/β MAPK activity in SCs from aged mice and, furthermore, that hyperactive p38α/β MAPK prevents asymmetric p38α/β MAPK signaling, thus disrupting asymmetric division and the generation of quiescent daughter cells (Fig. 6d) . The observations that partial inhibition of p38α/β MAPK in SCs from aged mice restores generation of Pax7 + cells, increases the numbers of SCs with asymmetric phospho-p38α/β MAPK, increases the self-renewal of SCs from aged mice by threefold and rescues the engraftment and maintenance of these cells in young host muscle strongly support this model. Near-complete inhibition of p38α/β MAPK virtually eliminates self-renewal, demonstrating that p38α/β MAPK is required for SC self-renewal 42 . Other published work has demonstrated that elevated p38α/β MAPK signaling promotes myoblast differentiation 39, 40 , which may exacerbate the failure of SCs from aged mice to expand irrespective of the surrounding environment. Together, these data support a critical role for p38α/β MAPK in SC self-renewal, suggesting that the subcellular localization of, duration of signaling by and timing of p38α/β MAPK activation are highly regulated to permit asymmetric division and SC self-renewal.
Although the role of FGFR1 in regulating SC self-renewal is less clear, previous observations that loss of FGFR1 signaling in vivo reduces skeletal muscle mass during development 27 , that FGFR1 is expressed in freshly isolated SCs 37 and that FGFR1 signaling represses myogenesis in SC-derived cell lines 26 suggest that FGFR1 signaling plays an important part in regulating SC function. Here, we have shown that ectopic ligand-independent activation of FGFR1 signaling restores asymmetric phospho-p38α/β MAPK activation, which is consistent with the rescue of self-renewal in culture of SCs from aged mice. Moreover, activation of ectopically expressed iFR1 promotes asymmetric colocalization of iFR1 and phospho-p38α/β MAPK, supporting a role for FGFR1 signaling in asymmetric SC division and self-renewal (Fig. 6d) . Our data are consistent with a role for FGFR1 in organizing an asymmetric signaling complex 33 that would asymmetrically activate p38α/β MAPK (Fig. 6d) . Consistent with this hypothesis are observations that FGFR1 signaling is disrupted in Sdc4-null mice 43 and that Sdc4-null SCs fail to engraft and expand when transplanted into wild-type muscle 23 . The attenuation of FGFR1 activation by FGF ligands in SCs from aged mice prevents asymmetric division, which promotes lineage commitment in both daughter cells and reduces self-renewal, thus reducing the stem cell population (Fig. 6d) .
The attenuation of intracellular responses initiated by extracellular FGF-2 in SCs from aged mice could arise either from changes in FGFR1 interactions with other cell surface proteins or from altered heparan sulfate, as FGF binding and signaling from FGFR1 requires a ternary complex comprising heparan sulfate, FGFR1 and an FGF ligand [44] [45] [46] . Thus, alterations in either FGFR1 or heparan sulfate, observed in other aging tissues 47, 48 , could contribute to the decline in signal transduction efficiency and the cell-autonomous loss of SC self-renewal. Consistent with this idea is the observation that FGF-2 abundance increases in muscles in aged mice 32 , which could be a compensatory response to loss of FGFR1 signaling. As ligandindependent activation of FGFR1 restored SC self-renewal, it seems likely that downstream FGFR1 signaling remains functional and responsive in SCs from aged mice. Although the precise mechanism of FGFR1 involvement in asymmetric activation of p38α/β MAPK is unclear, it is an area primed for future investigation. Manipulating stem cell self-renewal by enhancing FGFR1 signaling and reducing p38α/β MAPK activation to increase SC self-renewal represent potentially new therapeutic strategies for improving skeletal muscle regeneration and maintenance in the elderly population. 
ONLINE METHODS
Animal studies. Animal experiments in this study were performed in accordance with protocols approved by the Institutional Animal Care and Use Committee at the University of Colorado. Female C57BL/6 mice (Jackson Labs and the National Institute on Aging) were used for all ex vivo experiments. Transplant recipients were female C57BL/6 × DBA2 mice (Jackson Labs), whereas donor tissue was isolated from female βActGFP (FVB.Cg-Tg(CAG-EGFP)B5Nagy/J; Jackson Labs) mice referred to as βActGFP 23 , with sample size determined by power analysis of previous transplantation studies. Mice were used at 3-6 months of age (young, median 4 months) or 20-25 months of age (aged, median 23 months). βActGFP mice were aged in our facilities for transplantation assays.
Cell isolation, culture and transfection. Myofibers with associated SCs were isolated for immediate use as previously described 33 . For all experiments, myofibers were cultured in growth medium, F12-C (Life Science Products) + 15% horse serum ± 1.5 nM FGF-2 at 6% O 2 with daily medium and reagent changes. CFDA-SE (Invitrogen) was used at 10 µM, SU5402 (Tocris) at 25 µM, SB203580 (Tocris) at 10 µM and 25 µM, BIRB 796 (Millipore) at 10 µM, UO126 at 10 µM (AG Scientific) and B/B Homodimerizer at 100 µM (previously AP20187, Clontech). Sodium orthovanadate was used at 2 mM (Sigma-Aldrich) during fixation in phosphorylation experiments. DMSO was used as control for inhibitor treatment.
For AraC experiments, myofibers were cultured for 72 h and then incubated with or without 100 µM AraC (Sigma-Aldrich) for 48 h and fixed (day 5). The remaining myofibers were washed with growth medium and cultured for an additional 72 h without AraC (day 8, AraC recovery).
For transfection experiments, we purchased the plasmid pSH1/ M-FGFR1-Fv-FVl2-E containing the inducible FGFR1 (iFR1) construct from Addgene (Addgene plasmid 15285) 49 . We transfected the iFR1 construct or performed a mock transfection into myofiber-associated SCs with Lipofectamine 2000 (Invitrogen) 8 h after isolation. B/B Homodimerizer was added 24 h after transfection and added with daily medium changes until fixation at 48 h or 72 h.
For CFDA-SE retention assays, myofiber-associated cells were either cultured in growth medium or transfected as above and treated with B/B Homodimerizer or FGF-2 after 24 h. At 48 h, CFDA-SE in Dulbecco's PBS was added for 15 min and then myofibers were washed three times with growth medium to remove excess CFDA-SE. For each experiment, a subset of myofibers was fixed 30 min after CFDA-SE treatment to verify CFDA-SE uptake by all syndecan-4 + SCs. The remaining myofibers were transferred to growth medium (with FGF-2 or B/B Homodimerizer for iFR1 transfection experiments) and fixed at 72 h.
Myofiber transplantation. For heterochronic local transplantation assays, SCs from βActGFP mice were isolated alongside myofibers from wild-type mice. Cells were preplated (2-3 h) on an uncoated plate during myofiber isolation. A total of 2 × 10 4 cells were mixed with 50 myofibers in a 0.2-mL microcentrifuge tube in 0.2 mL warm growth medium containing 1.5 nM FGF-2. The mixture was rotated slowly at 37 °C for 3.5 h, and then myofibers were transferred to individual tissue culture plates for three successive washes with fresh growth medium to remove unattached cells and cultured for 24 or 72 h as described above.
Transplantation of myofiber-associated SCs to host tibialis anterior muscles was performed as previously described 23 except that myofibers were pretreated for 5 h with 1.5 nM FGF-2 or overnight with 10 µM SB or FGF-2 before injection. Five to seven myofibers were transplanted ( Supplementary  Fig. 1 ) to recipient mice with recipients randomly selected from a group of young C57BL/6 × DBA2 mice. Tibialis anterior muscles were harvested and sections processed as previously described 23 . To count the number of donor SCs, >10 fields (750 µm × 750 µm) were scored across serial 10-µm sections from midmuscle. The range in reported sample size is due to attrition of mice between injury and harvest.
Flow cytometry and analysis. For phosphorylation analysis, SCs were isolated and cultured in growth medium with 25 µM SU5402 (Tocris) or DMSO on uncoated plates for 16 h (starved of FGF-2). Additional SU5402 or DMSO and 2 mM sodium orthovanadate were added 1 h before FGF-2 stimulation. Cells were treated with or without FGF-2 in BSA for 5 min and then fixed in 4% paraformaldehyde at 4 °C, remaining at 4 °C throughout flow cytometry analysis. Sodium orthovanadate (Sigma-Aldrich) was added to all reagents during primary antibody staining. Cells were permeabilized with 0.1% Triton X-100 and then washed and blocked in 2% FBS. Cells (excluding unlabeled controls) were stained with 1:1,000 chicken anti-syndecan-4 (ref. 37) and 1:50 mouse antibody to phosphorylated p38 MAPK (Cell Signaling 9216S) for 1 h in 2% FBS in PBS and then for 30 min with secondary antibodies (anti-chick IgY conjugated to Alexa Fluor 647 and anti-mouse IgG conjugated to Alexa Fluor 488), and stained before analysis with DAPI. Cells were analyzed by flow cytometry (CyAN ADP Analyzer) and data analyzed in FlowJo 9.6. A gate was set to exclude small debris on the basis of previous analysis of freshly isolated SCs. Population shifts in syndecan-4 + phospho-p38 + cells were quantified by population comparison (Overton subtraction) in FlowJo.
Immunofluorescence. All cells and tissues were fixed in 4% paraformaldehyde and permeabilized as necessary with 0.1% Triton X-100. Muscle sections were prepared as previously described 23, 37 . All slides were blocked in 3% BSA 1 h at room temperature and stained in 1% BSA. Primary antibodies were incubated at 4 °C overnight, and secondary antibodies were incubated for 1 h at room temperature. DAPI staining was used to mark nuclei. The following primary antibodies were used: chicken antibody to syndecan-4 (1:500) 37 , chicken antibody to syndecan-3 (1:50) 37 Microscopy and image processing. A Leica TCS SP2 AOBS confocal microscope with Leica software, using an HC Plan Apochromat 20 × /0.70 IMM CORR CS lens, was used to image most muscle sections. A Zeiss 510 confocal microscope with Zen software, using a Plan-Apochromat 63 × /1.40 numeric aperture lens, was used to image SB203580-treated and control transplant sections. Micrographs of local transplantation assays were captured with a Nikon Eclipse E800 equipped with a Sensicam (Cooke) digital camera and Slidebook v4.1 (3i) software with a Plan Fluor 20 × /NA 0.50 PH1 DLL (Nikon) lens. All other myofiber experiments were imaged with a Leica DM RXA Spinning Disk confocal microscope with EM-CCD digital camera (Hamamatsu) with Metamorph software (Molecular Devices) using HC Plan APO 20 × /0.70 or HCX PL APO 40 × /0.85 CORR lenses. All digital microscopic images were acquired at room temperature. The mounting medium for cells and sections was Vectashield Mounting Medium (Vector). Images were processed and then scored with blinding in ImageJ64. As necessary, the brightness and contrast were adjusted linearly for the entire image and adjusted equivalently across the experimental image set. Muscle-section images are averaged z stacks with Tikhonov-Miller deconvolution (ImageJ64) of the syndecan-4, c-Met and laminin channels.
Microarray and analysis. Raw data were preprocessed using Genespring software (Agilent) and analyzed for differential gene expression changes occurring over time. For heat maps, individual probe set expression (log 2 ) was normalized to the mean relative expression (log 2 ) of all transcript probe sets to one gene across both ages. In the Affymetrix 430 v.2 mouse microarray, there may be multiple probe sets corresponding to different transcripts from a single gene; this is indicated by repeated transcript names in the figures and table.
Statistical analyses. All values represent the mean ± s.e.m. of at least three biological replicates except microarray data, which represent biological npg
